Evidence
Clin Geriatr Med. 2023 Feb;39(1):91-107. doi: 10.1016/j.cger.2022.07.005. Epub 2022 Oct 18.
ABSTRACT
Dementias encompass a range of debilitating neurologic conditions. Here, we summarize the neuropathology of common forms of dementia, focusing on Alzheimer disease (AD) and related dementias. AD is part of a spectrum of neurodegenerative diseases that consists of various protein inclusions (ie, proteinopathies) but other brain abnormalities are also related to dementia. Beta-amyloid and tau aggregates are hallmarks of AD. Other tissue substrates include Lewy bodies, TDP-43 inclusions, vascular brain lesions, and mixed pathologies. This review highlights the complexity of neurodegenerative and other disease substrates and summarizes topography of these lesions and concepts of mixed brain pathologies, resistance, and resilience.
PMID:36404035 | DOI:10.1016/j.cger.2022.07.005
Add to Google Keep
Estimated reading time: 2 minute(s)
Latest: Psychiatryai.com #RAISR4D
Cool Evidence: Engaging Young People and Students in Real-World Evidence ☀️
Real-Time Evidence Search [Psychiatry]
AI Research [Andisearch.com]
Neuropathology of the Common Forms of Dementia
🌐 90 Days
VR Related Evidence Matrix
- Profiles of Lifestyle Health Behaviors and Postmortem Dementia-Related Neuropathology
- Profiles of Lifestyle Health Behaviors and Postmortem Dementia-Related Neuropathology
- Influences of amyloid-beta and tau on white matter neurite alterations in dementia with Lewy bodies
- Disease and brain region specific immune response profiles in neurodegenerative diseases with pure and mixed protein pathologies
- When prion disease Isn't suspected: prion disease as the cause of terminal decline in chronic mixed dementia
- Ageing-Related Neurodegeneration and Cognitive Decline
- Exploring Psychosis in Neurodegenerative Dementia: Connecting Symptoms to Neurobiology
- Serum GFAP levels correlate with astrocyte reactivity, post-mortem brain atrophy and neurofibrillary tangles
- Pathological C-terminal phosphomimetic substitutions alter the mechanism of liquid-liquid phase separation of TDP-43 low complexity domain
- Hepatopancreatic metabolic disorders and their implications in the development of Alzheimer's disease and vascular dementia
- In vivo PET classification of tau pathologies in patients with frontotemporal dementia
- Types of memory, dementia, Alzheimer's disease, and their various pathological cascades as targets for potential pharmacological drugs
- Traumatic Brain Injury in Mice Generates Early-Stage Alzheimer's Disease Related Protein Pathology that Correlates with Neurobehavioral Deficits
- Disentangling and quantifying the relative cognitive impact of concurrent mixed neurodegenerative pathologies
- Neuroinflammation is associated with Alzheimer's disease co-pathology in dementia with Lewy bodies
- The six brain-specific TAU isoforms and their role in Alzheimer's disease and related neurodegenerative dementia syndromes
- Multiple system atrophy with amyloid-b-predominant Alzheimer's disease neuropathologic change
- Understanding age-related pathologic changes in TDP-43 functions and their consequence on RNA splicing and signalling in health and disease
- PPARs (Peroxisome Proliferator-activated Receptors) and Their Agonists in Alzheimer's Disease
- Amyloid-β and Phosphorylated Tau are the Key Biomarkers and Predictors of Alzheimer's Disease
- Is Alzheimer disease a disease?
- Distinctive whole-brain cell types predict tissue damage patterns in thirteen neurodegenerative conditions
- Neuropsychiatric symptoms profile and markers of Alzheimer disease-type pathology in patients with Lewy body dementias
- Biomarkers of Neurodegeneration and Alzheimer's Disease Neuropathology in Adolescents and Young Adults with Youth-Onset Type 1 or Type 2 Diabetes: A Proof-of-Concept Study
- Lecanemab blocks the effects of the Ab/fibrinogen complex on blood clots and synapse toxicity in organotypic culture
- Innate immune activation in neurodegenerative diseases
- Cortical-sparing chronic traumatic encephalopathy (CSCTE): a distinct subtype of CTE
- Cortical-sparing chronic traumatic encephalopathy (CSCTE): a distinct subtype of CTE
- Tau filaments with the chronic traumatic encephalopathy fold in a case of vacuolar tauopathy with VCP mutation D395G
- Associations of sleep disorders with all-cause MCI/dementia and different types of dementia - clinical evidence, potential pathomechanisms and treatment options: A narrative review
- Neuropathologic changes at age 90+ related to sleep duration 19 to 40 years earlier: The 90+ Study
- Psychosis in Neurodegenerative Dementias: A Systematic Comparative Review
- The complexity of extracellular vesicles: Bridging the gap between cellular communication and neuropathology
- Limbic-predominant age-related TDP-43 encephalopathy (LATE-NC): Co-pathologies and genetic risk factors provide clues about pathogenesis
- The effects of cholesterol and statins on Parkinson's neuropathology: a narrative review
- Association of Alzheimer's Disease and Other Neuropathologies with Functional Disability in Persons With and Without Dementia
- Unraveling the Dual Role of ADAM10: Bridging the Gap between Cancer and Alzheimer's Disease
- Production and characterization of novel monoclonal antibodies against pathological human TDP-43 proteins
- Mark4 ablation attenuates pathological phenotypes in a mouse model of tauopathy
- Nonpharmacological intervention therapies for dementia: potential break-even intervention price and savings for selected risk factors in the European healthcare system
- Postacute Care and Long-term Care for LGBTQ+ Older Adults
- Epidemiology and prevalence of dementia and Alzheimer's disease in American Indians: Data from the Strong Heart Study
- Genomic stress and impaired DNA repair in Alzheimer disease
- A cross-sectional study of α-synuclein seed amplification assay in Alzheimer's disease neuroimaging initiative: Prevalence and associations with Alzheimer's disease biomarkers and cognitive function
- Point prevalence of epilepsy in dementia: A "real-world" estimate
- Are age-related neurodegenerative diseases caused by a lack of the diet-derived compound ergothioneine?
- Prevalence and Determinants of Diagnosed Dementia: A Registry Linkage Study Linking Diagnosis of Dementia in the Population-Based HUNT Study to Registry Diagnosis of Dementia in Primary Care and Hospitals in Norway
- Shaping the future of preclinical development of successful disease-modifying drugs against Alzheimer's disease: a systematic review of tau propagation models
- A Review of the Common Neurodegenerative Disorders: Current Therapeutic Approaches and the Potential Role of Bioactive Peptides
- Clinical and Pathological Features of FTDP-17 with MAPT p.K298_H299insQ Mutation
- Reduced STMN2 and pathogenic TDP-43, two hallmarks of ALS, synergize to accelerate motor decline in mice
- Proton Pump Inhibitors and Cognitive Health: Review on Unraveling the Dementia Connection and Co-morbid Risks
- Age dependent path Integration deficit in 5xFAD mice
- Mitigation of TDP-43 toxic phenotype by an RGNEF fragment in amyotrophic lateral sclerosis models
- Reactive astrocytes secrete the chaperone HSPB1 to mediate neuroprotection
- Generation and characterization of monoclonal antibodies against pathologically phosphorylated TDP-43
- Postural control characteristics in Alzheimer's disease, dementia with Lewy bodies, and vascular dementia
- Clinical Arterial Spin-Labeling MR Imaging to Screen for Typical and Atypical Neurodegenerative Disease in the New Era of Alzheimer Treatment
- Associations of hospital-treated infections with subsequent dementia: nationwide 30-year analysis
- Therapeutics for neurodegenerative diseases by targeting the gut microbiome: from bench to bedside
- Therapeutics for neurodegenerative diseases by targeting the gut microbiome: from bench to bedside
- Lateral geniculate body is spared of tau pathology in Pick disease
- The predominance of "astrocytic" intranuclear inclusions in neuronal intranuclear inclusion disease manifesting encephalopathy-like symptoms: A case series with brain biopsy
- Amyloid, Crohn's disease, and Alzheimer's disease - are they linked?
Evidence Blueprint
Neuropathology of the Common Forms of Dementia
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
More Evidence
Neuropathology of the Common Forms of Dementia
🌐 365 Days
VR Related Evidence Matrix
- Secondary Protein Aggregates in Neurodegenerative Diseases: Almost the Rule Rather than the Exception
- Targeted examination of amyloid beta and tau protein accumulation via positron emission tomography for the differential diagnosis of Alzheimer's disease based on the A/T(N) research framework
- Incidence and morphology of secondary TDP-43 proteinopathies: Part 2
- Profiles of Lifestyle Health Behaviors and Postmortem Dementia-Related Neuropathology
- Profiles of Lifestyle Health Behaviors and Postmortem Dementia-Related Neuropathology
- Transcriptomic evaluation of tau and TDP-43 synergism shows tauopathy predominance and reveals potential modulating targets
- Transcriptomic evaluation of tau and TDP-43 synergism shows tauopathy predominance and reveals potential modulating targets
- The contribution of DNA methylation to the (dys)function of oligodendroglia in neurodegeneration
- Influences of amyloid-beta and tau on white matter neurite alterations in dementia with Lewy bodies
- Disease and brain region specific immune response profiles in neurodegenerative diseases with pure and mixed protein pathologies
- Polypathologic associations with grey matter atrophy in neurodegenerative disease
- Morphological characteristics differentiate dementia with Lewy bodies from Parkinson disease with and without dementia
- Identifying and Diagnosing TDP-43 Neurodegenerative Diseases in Psychiatry
- Ischemia-Reperfusion Programming of Alzheimer's Disease-Related Genes-A New Perspective on Brain Neurodegeneration after Cardiac Arrest
- Lysosomal polygenic risk is associated with the severity of neuropathology in Lewy body disease
- Pathophysiology of dementia
- When prion disease Isn't suspected: prion disease as the cause of terminal decline in chronic mixed dementia
- Senile plaque-associated transactive response DNA-binding protein 43 in Alzheimer's disease: A case report spanning 16 years of memory loss
- Autophagy Markers Are Altered in Alzheimer's Disease, Dementia with Lewy Bodies and Frontotemporal Dementia
- Relative contributions of mixed pathologies to cognitive and functional symptoms in brain donors exposed to repetitive head impacts
- Ageing-Related Neurodegeneration and Cognitive Decline
- Insights into the Pathological Basis of Dementia from Population Based Neuropathology Studies
- Elucidating distinct molecular signatures of Lewy body dementias
- TDP-43 and Alzheimer's Disease Pathology in the Brain of a Harbor Porpoise Exposed to the Cyanobacterial Toxin BMAA
- Exploring Psychosis in Neurodegenerative Dementia: Connecting Symptoms to Neurobiology
- The Relationship Between First Presenting Neuropsychiatric Symptoms in Older Adults and Autopsy-Confirmed Memory Disorders
- Different dysregulations of CYFIP1 and CYFIP2 in distinct types of dementia
- Ketone bodies mediate alterations in brain energy metabolism and biomarkers of Alzheimer's disease
- Disrupting pathologic phase transitions in neurodegeneration
- Role of ketogenic diet in neurodegenerative diseases focusing on Alzheimer diseases: The guardian angle
- Role of ketogenic diet in neurodegenerative diseases focusing on Alzheimer diseases: The guardian angle
- Serum GFAP levels correlate with astrocyte reactivity, post-mortem brain atrophy and neurofibrillary tangles
- Cellular and animal models to investigate pathogenesis of amyloid aggregation in neurodegenerative diseases
- Pathological Markers of Alzheimer's Disease and Related Dementia in the Rhesus Macaque Amygdala
- Pathological C-terminal phosphomimetic substitutions alter the mechanism of liquid-liquid phase separation of TDP-43 low complexity domain
- Cerebral Small Vessel Disease, Hypertension, and Vascular Contributions to Cognitive Impairment and Dementia: Dementia Series
- Hepatopancreatic metabolic disorders and their implications in the development of Alzheimer's disease and vascular dementia
- Dysregulation of stress granule dynamics by DCTN1 deficiency exacerbates TDP-43 pathology in Drosophila models of ALS/FTD
- In vivo PET classification of tau pathologies in patients with frontotemporal dementia
- Types of memory, dementia, Alzheimer's disease, and their various pathological cascades as targets for potential pharmacological drugs
- Alzheimer's disease biomarker analysis using targeted mass spectrometry
- Cryptic splicing of stathmin-2 and UNC13A mRNAs is a pathological hallmark of TDP-43-associated Alzheimer's disease
- Traumatic Brain Injury in Mice Generates Early-Stage Alzheimer's Disease Related Protein Pathology that Correlates with Neurobehavioral Deficits
- Disentangling and quantifying the relative cognitive impact of concurrent mixed neurodegenerative pathologies
- A data-driven study of Alzheimer's disease related amyloid and tau pathology progression
- Distribution of ubiquilin 2 and TDP-43 aggregates throughout the CNS in UBQLN2 p.T487I-linked amyotrophic lateral sclerosis and frontotemporal dementia
- Cerebrospinal fluid biomarker panel for synaptic dysfunction in a broad spectrum of neurodegenerative diseases
- Latest advances in mechanisms of epileptic activity in Alzheimer's disease and dementia with Lewy Bodies
- Age-related hearing loss and dementia-related neuropathology: An analysis of the United Kingdom brains for dementia research cohort
- Neuroinflammation is associated with Alzheimer's disease co-pathology in dementia with Lewy bodies
- Nuclear Expression of TDP-43 Is Linked with Morphology and Ubiquitylation of Cytoplasmic Aggregates in Amyotrophic Lateral Sclerosis
- Dem-Aging: autophagy-related pathologies and the "two faces of dementia"
- Interactions between vascular burden and amyloid-β pathology on trajectories of tau accumulation
- Dementia with Lewy bodies: old and new knowledge - Part 1: clinical aspects and diagnostics
- Identifying Mixed Dementia With Lewy Bodies and Alzheimer Disease Using Multitracer PET Imaging: A Case Study
- Healthy Lifestyle and Cognition in Older Adults With Common Neuropathologies of Dementia
- Neurodegenerative pathologies associated with behavioral and psychological symptoms of dementia in a community-based autopsy cohort
- Neuropathology of Alzheimer's Disease
- Molecular pathology of neurodegenerative diseases by cryo-EM of amyloids
- Lewy body pathology modifies risk factors for cerebral amyloid angiopathy when comorbid with Alzheimer's disease pathology
- The multifaceted functions of β-arrestins and their therapeutic potential in neurodegenerative diseases
- Dysregulation of Ion Channels and Transporters and Blood-Brain Barrier Dysfunction in Alzheimer's Disease and Vascular Dementia
- Dysregulation of Ion Channels and Transporters and Blood-Brain Barrier Dysfunction in Alzheimer's Disease and Vascular Dementia
- Longitudinal motor decline in dementia with Lewy bodies, Parkinson disease dementia, and Alzheimer's dementia in a community autopsy cohort